Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takefumi Komiya

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
European Journal of Cancer (Oxford, England : 1990)|July 8, 2015
PD-L1 expression in small cell lung cancerTakefumi Komiya, Rashna Madan
Asian Pacific Journal of Cancer Prevention : APJCP|January 29, 2022
Induction Immunotherapy Followed by Thoracic Radiation without Chemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer: A Case SeriesSrikiran Dasari, Takefumi Komiya
Journal of Cancer Research and Clinical Oncology|September 25, 2019
Brain metastasis as exclusion criteria in clinical trials involving extensive-stage small cell lung cancerAndy Wang, Takefumi Komiya
Journal of the National Cancer Institute|July 3, 2003
New leads suggest a clinically relevant genotype-phenotype relationship for the p53 geneFrederic J Kaye, Takefumi Komiya
JAMA|April 27, 2016
TP53 Gene and Cancer Resistance in ElephantsRaymond P Perez, Takefumi Komiya
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 15, 2014
Who wins the race of predicting chemoradiation-induced esophagitis? Is there anyone else to join the competition? In response to Tang et alTakefumi Komiya, Shana L Palla
Frontiers in Oncology|October 20, 2018
Updates in the Clinical Development of Epacadostat and Other Indoleamine 2,3-Dioxygenase 1 Inhibitors (IDO1) for Human CancersTakefumi Komiya, Chao H Huang
Asian Pacific Journal of Cancer Prevention : APJCP|January 28, 2023
Exclusion of Patients with Autoimmune Disease in Lung Cancer Clinical TrialsShamsher S Khan, Takefumi Komiya
Thoracic Cancer|October 6, 2021
Prognostic impact of chronological age on efficacy of immune checkpoint inhibitors in non-small-cell lung cancer: Real-world data from 86 173 patientsShinkichi Takamori, Mototsugu Shimokawa, Takefumi Komiya
Medical Oncology (Northwood, London, England)|March 20, 2021
Role of thoracic radiation in extensive stage small cell lung cancer: a NCDB analysisTakefumi Komiya, Emily Powell, Shinkichi Takamori
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
European Journal of Cancer (Oxford, England : 1990)|July 8, 2015
PD-L1 expression in small cell lung cancerTakefumi Komiya, Rashna Madan
Asian Pacific Journal of Cancer Prevention : APJCP|January 29, 2022
Induction Immunotherapy Followed by Thoracic Radiation without Chemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer: A Case SeriesSrikiran Dasari, Takefumi Komiya
Journal of Cancer Research and Clinical Oncology|September 25, 2019
Brain metastasis as exclusion criteria in clinical trials involving extensive-stage small cell lung cancerAndy Wang, Takefumi Komiya
Journal of the National Cancer Institute|July 3, 2003
New leads suggest a clinically relevant genotype-phenotype relationship for the p53 geneFrederic J Kaye, Takefumi Komiya
JAMA|April 27, 2016
TP53 Gene and Cancer Resistance in ElephantsRaymond P Perez, Takefumi Komiya
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 15, 2014
Who wins the race of predicting chemoradiation-induced esophagitis? Is there anyone else to join the competition? In response to Tang et alTakefumi Komiya, Shana L Palla
Frontiers in Oncology|October 20, 2018
Updates in the Clinical Development of Epacadostat and Other Indoleamine 2,3-Dioxygenase 1 Inhibitors (IDO1) for Human CancersTakefumi Komiya, Chao H Huang
Asian Pacific Journal of Cancer Prevention : APJCP|January 28, 2023
Exclusion of Patients with Autoimmune Disease in Lung Cancer Clinical TrialsShamsher S Khan, Takefumi Komiya
Thoracic Cancer|October 6, 2021
Prognostic impact of chronological age on efficacy of immune checkpoint inhibitors in non-small-cell lung cancer: Real-world data from 86 173 patientsShinkichi Takamori, Mototsugu Shimokawa, Takefumi Komiya
Medical Oncology (Northwood, London, England)|March 20, 2021
Role of thoracic radiation in extensive stage small cell lung cancer: a NCDB analysisTakefumi Komiya, Emily Powell, Shinkichi Takamori
Pageof 7